Lixte Biotechnologys share price fell hard after it revealed a Bitcoin treasury, while firms stashing Ethereum have been surging of late.
Lixte Biotechnology’s share price fell hard after it revealed a Bitcoin treasury, while firms stashing Ethereum have been surging of late.
π Related Reading
- π° S&P Assigns First-Ever Credit Rating to a DeFi Protocol, Rates Sky at B-
- π° Classover Taps $500M Convertible Note Deal to Boost Solana Treasury Strategy
π You Might Also Be Interested In
S&P Assigns First-Ever Credit Rating to a DeFi Protocol, Rates Sky at B-
Classover Taps $500M Convertible Note Deal to Boost Solana Treasury Strategy
Tokenized stock trading live on Kraken, Bybit and Solanaβs DeFi ecosystem
π‘ Stay updated with the latest cryptocurrency news and insights by following our website! π Bookmark this site to get first-hand blockchain and digital currency news!